Morphological profiling data resource enables prediction of chemical compound properties
Christopher Wolff,
Martin Neuenschwander,
Carsten Jörn Beese,
Divya Sitani,
Maria C. Ramos,
Alzbeta Srovnalova,
María José Varela,
Pavel Polishchuk,
Katholiki E. Skopelitou,
Ctibor Škuta,
Bahne Stechmann,
José Brea,
Mads Hartvig Clausen,
Petr Dzubak,
Rosario Fernández-Godino,
Olga Genilloud,
Marian Hajduch,
María Isabel Loza,
Martin Lehmann,
Jens Peter von Kries,
Han Sun,
Christopher Schmied
Affiliations
Christopher Wolff
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany
Martin Neuenschwander
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany
Carsten Jörn Beese
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany
Divya Sitani
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany
Maria C. Ramos
Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía. Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, 18016 Armilla, Granada, Spain
Alzbeta Srovnalova
Institute of Molecular and Translational Medicine, Palacky University and University Hospital in Olomouc, Faculty of Medicine and Dentistry, Hněvotínská 5, 77515 Olomouc, Czech Republic
María José Varela
Biofarma Research Group, Centro de Investigación CIMUS, Departamento de Farmacología, Facultad de Farmacia, Instituto de Investigaciones Sanitarias IDIS, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
Pavel Polishchuk
Institute of Molecular and Translational Medicine, Palacky University and University Hospital in Olomouc, Faculty of Medicine and Dentistry, Hněvotínská 5, 77515 Olomouc, Czech Republic
CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 14220 Prague 4, Czech Republic
Biofarma Research Group, Centro de Investigación CIMUS, Departamento de Farmacología, Facultad de Farmacia, Instituto de Investigaciones Sanitarias IDIS, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
Institute of Molecular and Translational Medicine, Palacky University and University Hospital in Olomouc, Faculty of Medicine and Dentistry, Hněvotínská 5, 77515 Olomouc, Czech Republic
Rosario Fernández-Godino
Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía. Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, 18016 Armilla, Granada, Spain
Olga Genilloud
Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía. Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, 18016 Armilla, Granada, Spain
Marian Hajduch
Institute of Molecular and Translational Medicine, Palacky University and University Hospital in Olomouc, Faculty of Medicine and Dentistry, Hněvotínská 5, 77515 Olomouc, Czech Republic
María Isabel Loza
Biofarma Research Group, Centro de Investigación CIMUS, Departamento de Farmacología, Facultad de Farmacia, Instituto de Investigaciones Sanitarias IDIS, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
Martin Lehmann
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany
Jens Peter von Kries
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany; Corresponding author
Han Sun
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany; Corresponding author
Christopher Schmied
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany; EU-OPENSCREEN ERIC, Campus Berlin-Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany; Corresponding author
Summary: Morphological profiling with the Cell Painting assay has emerged as a promising method in drug discovery research. The assay captures morphological changes across various cellular compartments enabling the rapid prediction of compound bioactivity. We present a comprehensive morphological profiling resource using the carefully curated and well-annotated EU-OPENSCREEN Bioactive compounds. The data were generated across four imaging sites with high-throughput confocal microscopes using the Hep G2 as well as the U2 OS cell lines. We employed an extensive assay optimization process to achieve high data quality across the different sites. An analysis of the extracted profiles validates the robustness of the generated data. We used this resource to compare the morphological features of the different cell lines. By correlating the profiles with overall activity, cellular toxicity, several specific mechanisms of action (MOAs), and protein targets, we demonstrate the dataset’s potential for facilitating more extensive exploration of MOAs.